NASDAQ: BOLT
Bolt Biotherapeutics Inc Stock Ownership - Who owns Bolt Biotherapeutics?

Insider buying vs selling

Have Bolt Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sarah NemecSenior VP Finance and PAO2024-12-162,500$0.50
$1.24kBuy
William P. QuinnPresident CEO and CFO2024-12-162,500$0.50
$1.24kBuy

1 of 1

BOLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BOLT insiders and whales buy or sell their stock.

BOLT Shareholders

What type of owners hold Bolt Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital VIII LLC307.04%5,885,846$34.84MInsider
Tang Capital Management LLC198.89%3,812,773$22.57MInstitution
Holdings A. Novo193.22%3,703,991$21.93MInsider
Vivo Capital LLC183.69%3,521,291$20.85MInstitution
Edgar Engleman171.80%3,293,286$19.50MInsider
James Healy143.69%2,754,437$16.31MInsider
Sofinnova Venture Partners X LP143.69%2,754,437$16.31MInsider
Sofinnova Investments Inc143.69%2,754,437$16.31MInstitution
Pivotal Bioventure Partners Investment Advisor LLC98.67%1,891,467$11.20MInstitution
Mahendra Shah75.55%1,448,286$8.57MInsider

1 of 3

BOLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLT47.85%52.15%Net Buying
ACXP14.90%10.95%Net Buying
SNSE9.58%90.42%Net Selling
ABP2.59%53.89%Net BuyingNet Buying
EQ24.25%40.26%Net Selling

Bolt Biotherapeutics Stock Ownership FAQ

Who owns Bolt Biotherapeutics?

Bolt Biotherapeutics (NASDAQ: BOLT) is owned by 955.98% institutional shareholders, 1,041.74% Bolt Biotherapeutics insiders, and 0.00% retail investors. Vivo Capital VIII LLC is the largest individual Bolt Biotherapeutics shareholder, owning 5.89M shares representing 307.04% of the company. Vivo Capital VIII LLC's Bolt Biotherapeutics shares are currently valued at $34.84M.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.